ibalizumab-uiyk (Trogarzo)

From Aaushi
Jump to navigation Jump to search

Indications

Dosage

Adverse effects

More general terms

References

  1. Brown T FDA Approves Ibalizumab for Multidrug-Resistant HIV-1. Medscape - Mar 06, 2018. https://www.medscape.com/viewarticle/893512
    FDA News Release. March 6, 2018 FDA approves new HIV treatment for patients who have limited treatment options. https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm599657.htm